In SLE, pDCs are activated by specific IFN immune complexes (ICs), derived from autoantibodies and endogenous or exogenous nucleic acid-binding proteins, and produce IFN-I (48). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.